Search Market Research Report
Genome Sequencing Market Size, Share Global Analysis Report, 2021 – 2026
Genome Sequencing Market By Type (Products and Services), By Technology (Polymerase Chain Reaction (PCR), Sanger Sequencing, Non-Sanger’s Sequencing, Microarray, and Next-Generation Sequencing (NGS)), By Application (Diagnostic, Research, and Others), By End-User (Healthcare Facilities & Diagnostic Centers, Research Institutes, and Pharmaceutical & Biotechnological Companies), And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026
Industry Insights
[227+ Pages Report] According to Facts & Factors, the “Global Genome Sequencing Market” report clarifies the complete market overview and breakdown structure. In this report, the global genome sequencing market witnessed a value of USD 27 Billion by 2020 and with growth at a CAGR of 20% is projected to reach a value of USD 95 Billion by 2026.
Market Overview
Genome sequencing is a technology that refers to the sequencing of the entire organism. This technique helps figure out the entire sequence or order of the DNA nucleotides/bases which includes the order of As, Cs, Gs, and Ts that form the backbone of an organism's DNA. In the human genome, there are around 3 billion genetic letters. The hi-end machines are used to read and sequence the genomes. Genome sequencing helps in the discovery of biomarkers, study of personalized medication, oncology studies, forensics, and others. In healthcare, there is a shift from conventional methods to precision medicines with the help of genomics. Currently, the most useful tool is whole-genome sequencing.
The rise in R&D activities and the increasing number of genome mapping programs across the globe are projected to propel the global genome sequencing market. The development of tools such as Neoantigen Presentation Score (NEOPS) is one of the major factors contributing to the industry growth.
Industry Growth Factors
The growing demand for the prevention, treatment, and management of diseases is anticipated to boost the demand for genome sequencing over the forecast period. Additionally, the rising investments in research and advancements in the field of bioinformatics will further escalate market growth. The sudden onset of the COVID-19 pandemic has urged healthcare facilities, biotechnology companies, and the government to invest in research activities related to the development of vaccines or novel treatments. Moreover, the positive potentials of genome sequencing have encouraged start-ups to provide sequencing services for further application in genetic diseases, ancestry, and others.
The major factor contributing to the genome sequencing industry is the rising number of government genome projects such as the Personalized Medicine Programme, Saudi Human Genome Program, etc. The introduction of NGS has helped shift to personalized medicines and also reduce the cost of sequencing. However, the lack of awareness, high-costing tools, and shortage of skilled technicians are likely to hinder the genome sequencing market growth.
Segmentation Analysis
The global genome sequencing market is segmented based on type, technology, application, end-user, and regions.
Based on type, the global genome sequencing market is divided into products and services. The product segment is projected to hold the largest market share over the forecast period. The growth is primarily due to the rising demand, utilization of consumables, and launch of new automated products & software. On the basis of technology, the market is categorized into polymerase chain reaction (PCR), Sanger sequencing, Non-Sanger’s sequencing, microarray, and next-generation sequencing (NGS). From these, the polymerase chain reaction (PCR) accounts for the largest market share in the global genome sequencing market due to its growing use and easy availability across the globe. By application, the genome sequencing market is classified into diagnostic, research, and others. The diagnostic segment accounts for the highest market share.
The dominance is majorly contributed to the rising use of NGS technology by clinical diagnostics and the rising demand for direct-to-consumer genetic testing. Additionally, the growing popularity of nutrigenomics for providing diet plans considering the diseases depending on the patients’ genes is likely to bolster the market growth over the forecast period. Based on end-user, the market is segmented into healthcare facilities & diagnostic centers, research institutes, and pharmaceutical & biotechnological companies. The research institutes segment is expected to dominate the global genome sequencing market due to the increasing government funding and support in the research field.
Report Scope
Report Attribute |
Details |
Market Size in 2020 |
USD 27 Billion |
Projected Market Size in 2026 |
USD 95 Billion |
CAGR Growth Rate |
20% CAGR |
Base Year |
2020 |
Forecast Years |
2021-2026 |
Key Market Players |
Illumina, Inc., BGI, IntegraGen, Bio-Rad Laboratories, QIAGEN, Danaher, Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Genome Electric Company, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd., among others. |
Key Segment |
By Type, By Technology, By Application, By End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Analysis
North America is expected to dominate the global genome sequencing market due to the increasing adoption of sequencing technologies and the growing demand for personalized medicines in this region. Moreover, the launch of Ancestryhealth, a next-generation sequencing technology to identify the blood disorder, colon cancer, breast cancer, and heart diseases related genes in this region will further propel the market over the forecast period. The Asia Pacific is anticipated to exhibit the highest growth rate due to the rising demand for sequencing and testing of genes in China.
Competitive Players
Some of the key players participating in the global genome sequencing market include :
- Illumina Inc.
- BGI
- IntegraGen
- Bio-Rad Laboratories
- QIAGEN
- Danaher
- Pacific Biosciences of California Inc.
- Oxford Nanopore Technologies
- Genome Electric Company
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
By Type Segment Analysis
- Products
- Instruments & Software
- Consumables
- Services
By Technology Segment Analysis
- Polymerase Chain Reaction (PCR)
- Sanger Sequencing
- Non-Sanger’s Sequencing
- Microarray
- Next-Generation Sequencing (NGS)
By Application Segment Analysis
- Diagnostic
- Research
- Others
By End-User Segment Analysis
- Healthcare Facilities & Diagnostic Centers
- Research Institutes
- Pharmaceutical & Biotechnological Companies
By Regional Segment Analysis
- North America
- U.S.
- Canada
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Table of Content
Industry Major Market Players
- Illumina Inc.
- BGI
- IntegraGen
- Bio-Rad Laboratories
- QIAGEN
- Danaher
- Pacific Biosciences of California Inc.
- Oxford Nanopore Technologies
- Genome Electric Company
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors